「io」の検索結果

Claude Codeの作業状況や決定事項、次の手順をプロジェクト別に保存するスキル。別のセッションでも概要を読み込み、前回の続きから作業を再開できます。

• 終了前に進捗と次の手順を保存
• 前回のセッションから再開したいとき
• 複数プロジェクトの状況確認

Guide for implementing Shell-based navigation in .NET MAUI apps. Covers AppShell setup, visual hierarchy (FlyoutItem, TabBar, Tab, ShellContent), URI-based navigation with GoToAsync, route registration, query parameters, back navigation, flyout and tab configuration, navigation events, and navigation guards. Use when: setting up Shell navigation, adding tabs or flyout menus, navigating between pages with GoToAsync, passing parameters between pages, registering routes, customizing back button behavior, or guarding navigation with confirmation dialogs. Do not use for: deep linking from external URLs (see .NET MAUI deep linking documentation), data binding on pages (use maui-data-binding), dependency injection setup (use maui-dependency-injection), or NavigationPage-only apps that don't use Shell.

日本語の概要は準備中です。原文の説明を表示しています。

Scan a codebase for missing, janky, or inconsistent UI motion and fix it with transitions.dev recipes. ALWAYS use this skill when the user's message is or contains a transitions-agent command (npx transitions-agent, npx transitions-agent fix, any variant) - the command is a request for the full guided flow, not just command execution. Also use when the user asks about UI transitions, animations, motion quality, a motion score, janky or missing transitions, "polish the motion", "fix the animations", or whether the motion is good after UI changes.

日本語の概要は準備中です。原文の説明を表示しています。

Typst academic paper assistant for existing `.typ` paper projects in English or Chinese. Use this skill whenever the user wants to compile, audit, or improve a Typst paper, including format checks, bibliography validation for BibTeX or Hayagriva, grammar/sentence/logic review, expression polishing, translation, title optimization, pseudocode review, algorithm block cleanup, de-AI editing, experiment-section review, table structure validation, three-line table generation, abstract structure diagnosis, or journal adaptation. Trigger even when the user only mentions one Typst file, one bibliography issue, one pseudocode block, one section rewrite, "three-line table", "check abstract", or "reformat for another journal". Also trigger when the user mentions ".typ files", "typst compile error", "typst export", "typst bibliography", `algorithm-figure`, `lovelace`, or `algorithmic` even without saying the word "Typst" explicitly.

日本語の概要は準備中です。原文の説明を表示しています。

This skill covers Bayesian estimation and inference in quantitative social science. Use when the user is specifying priors, running MCMC, diagnosing chain convergence, or reporting posterior summaries — including hierarchical models, Bayesian structural models, and small-sample settings where priors regularize. Triggers on "Bayesian estimation", "Bayesian inference", "MCMC", "Markov chain Monte Carlo", "Stan", "PyMC", "NumPyro", "prior", "posterior", "credible interval", "Bayesian structural", "Bayesian BLP", "Bayesian DSGE", "hierarchical model", "random effects Bayesian", "posterior predictive check", "Bayes factor", "prior predictive check", "NUTS", "HMC", "Hamiltonian Monte Carlo", "R-hat", "rhat", "effective sample size", "ESS", "Bayesian calibration", "posterior distribution", "prior elicitation", "weakly informative prior", "brms", "rstanarm", "cmdstanpy", "pymc", "arviz".

日本語の概要は準備中です。原文の説明を表示しています。

Opinionated Bayesian modeling workflow with PyMC and ArviZ. Contains critical guardrails (nutpie sampler, prior/posterior predictive checks, LOO-PIT calibration, prior sensitivity checks, 94% HDI, non-centered parameterizations, reproducible seeds) that agents won't apply unprompted — always consult before writing Bayesian model code. Trigger on: building probabilistic/Bayesian models, prior elicitation, MCMC inference, convergence diagnostics (divergences, R-hat, ESS), model comparison (LOO-CV, ELPD, stacking weights), hierarchical/multilevel models, count regressions, logistic regression with uncertainty, prior sensitivity analysis, reporting Bayesian results, or mentions of PyMC, ArviZ, InferenceData, credible intervals, posterior distributions, shrinkage, uncertainty quantification. Also trigger for model comparison, diagnosing sampling problems, choosing priors, or presenting stats to non-technical audiences.

日本語の概要は準備中です。原文の説明を表示しています。

Classical end-to-end empirical analysis workflow in the traditional Stata ecosystem — native Stata + reghdfe + ivreg2 + csdid + did_imputation + eventstudyinteract + sdid + rdrobust + rddensity + synth + synth_runner + psmatch2 + teffects + ebalance + coefplot + esttab + asdoc + binscatter. **Defaults to economics empirical-paper style** (AER / QJE / AEJ) — every run produces a publication-ready output set with a multi-column regression table (M1→M6 progressive controls/FE) as the centerpiece, plus Table 1 (descriptives), mechanism / heterogeneity / robustness tables, and event-study + coefficient + trend figures. Covers the full 8-step Stata pipeline an applied economist runs on every paper — (1) data import & cleaning (use/import, destring, misstable, duplicates, merge assert), (2) variable construction (gen/egen/winsor2/xtile/xtset with L./F./D.), (3) descriptive statistics & Table 1 (tabstat/balancetable/asdoc), (4) classical diagnostic tests (sktest/swilk/hettest/imtest/xtserial/xttest3/vif/dfuller/kpss/hausman/estat overid), (5) baseline modeling (reg/xtreg/reghdfe/ivreg2/ivregress/csdid/did_imputation/eventstudyinteract/sdid/rdrobust/synth/psmatch2/teffects/heckman/qreg/ppmlhdfe), (6) robustness battery (bacondecomp/honestdid/rwolf/ritest/wildbootstrap/oster), (7) further analysis (subgroup/triple-diff/interactions/medsem/marginsplot/binscatter by group), (8) publication-ready tables & figures (esttab/outreg2/estout/coefplot/marginsplot/rdplot/twoway combined). **Also covers two parallel domain modes that share the same 8-step scaffolding** — **Mode A — Epidemiology / public health** (target-trial emulation, IPTW + g-formula + TMLE doubly-robust triplet via `teffects ipw` / `teffects ipwra` / `teffects aipw` / `eltmle`, Mendelian randomization via `mrrobust` (IVW / Egger / weighted median) and `mregger` / `mrpresso`, KM / Cox / AFT / RMST survival via `sts` / `stcox` / `streg` / `strmst2`, E-value sensitivity via `evalue` (Linden-Mathur), principal stratification — STROBE / TRIPOD reporting), and **Mode B — ML causal inference** (DML via `ddml` / `pdslasso`, S/T/X/R/DR meta-learners via `crforest` and `ddml interactive`, causal forest via `crforest` / `cforest`, BART/BCF via `bart` / `bartCause`-style externals, CATE distribution + policy tree via `crforest`, off-policy evaluation, conformal causal externals, fairness audit, DAG learning via `pcalg` / external Python callouts). Use when the user asks for a complete Stata empirical analysis, wants a reproducible .do-file pipeline, needs a Stata counterpart to the Python StatsPAI / Full-empirical-analysis-skill, or names a specific Stata step in isolation ("run reghdfe with two-way clustering", "csdid event study", "winsor2 at 1%", "esttab to LaTeX", "coefplot with CI", "ivreg2 weak-IV test", "synth_runner placebos", "teffects psmatch balance check"). Mode A triggers on "target trial emulation Stata", "teffects ipw aipw", "eltmle", "mrrobust", "mregger weighted median", "stcox AFT survival", "strmst2", "evalue Stata", "STROBE Stata", "公共健康 Stata", "流行病学 Stata". Mode B triggers on "ddml Stata", "pdslasso", "crforest causal forest Stata", "policy tree Stata", "因果机器学习 Stata".

日本語の概要は準備中です。原文の説明を表示しています。

Generates complete reference-grounded single-drug adverse-effect network-pharmacology research designs from a user-provided drug, adverse event, and desired evidence depth. Always use this skill when a user wants to design, plan, or upgrade a conventional network-pharmacology study centered on one fixed drug and one fixed adverse-effect endpoint, using drug-target prediction, adverse-event target collection, overlap analysis, PPI hub prioritization, enrichment interpretation, molecular docking, and optional orthogonal transcriptomic or literature validation. Covers five study patterns (canonical hub-first, cardiotoxicity or electrophysiology-oriented, immune-inflammatory adverse effect, organ-toxicity pathway context, translational validation) and always outputs four workload configs (Lite / Standard / Advanced / Publication+) with a recommended primary plan, dependency/evidence map, step-by-step workflow, figure plan, validation strategy, minimal executable version, publication upgrade path, verified-reference pack, and self-critical risk review.

日本語の概要は準備中です。原文の説明を表示しています。

Generates complete phenotype-scoring bioinformatics research designs for any disease context and any user-defined phenotype, pathway, process, signature, or molecular program. Use when a study centers on gene-set or feature-set definition, intersection with DEGs or candidate features, phenotype scoring, feature selection, diagnostic or stratification assessment, immune or cellular-resolution interpretation, network analysis, and optional orthogonal validation. Covers five study patterns (signature discovery, phenotype scoring, feature selection, immune/cellular interpretation, multi-layer validation) and always outputs Lite / Standard / Advanced / Publication+ with a recommended primary plan, stepwise workflow, figure plan, validation hierarchy, minimal executable version, publication upgrade path, and strictly verified literature retrieval.

日本語の概要は準備中です。原文の説明を表示しています。

Generates complete reference-grounded single-drug adverse-effect network-pharmacology research designs from a user-provided drug, adverse event, and desired evidence depth. Always use this skill when a user wants to design, plan, or upgrade a conventional network-pharmacology study centered on one fixed drug and one fixed adverse-effect endpoint, using drug-target prediction, adverse-event target collection, overlap analysis, PPI hub prioritization, enrichment interpretation, molecular docking, and optional orthogonal transcriptomic or literature validation. Covers five study patterns (canonical hub-first, cardiotoxicity or electrophysiology-oriented, immune-inflammatory adverse effect, organ-toxicity pathway context, translational validation) and always outputs four workload configs (Lite / Standard / Advanced / Publication+) with a recommended primary plan, dependency/evidence map, step-by-step workflow, figure plan, validation strategy, minimal executable version, publication upgrade path, verified-reference pack, and self-critical risk review.

日本語の概要は準備中です。原文の説明を表示しています。

Use this skill for planning, testing, and safely executing PostgreSQL schema migrations — especially when working with production data or shared databases. **Trigger when user asks to:** - Test a schema migration before applying it to production - Add, remove, or rename columns safely on a live table - Change a column's data type without downtime - Add or drop indexes, constraints, or foreign keys on large tables - Understand which ALTER TABLE operations lock the table - Roll back a failed migration - Plan a zero-downtime migration strategy - Fork a database to test a migration safely **Keywords:** migration, schema change, ALTER TABLE, add column, drop column, rename column, change type, zero downtime, lock, AccessExclusiveLock, concurrent index, forking, rollback, backfill, deploy Covers: lock-level reference for every common DDL operation, safe migration patterns, fork-based testing, zero-downtime column changes, index creation, constraint addition, backfill strategies, pre/post-migration validation, and rollback planning.

日本語の概要は準備中です。原文の説明を表示しています。

Estimates tumor fraction (the genome-wide proportion of cfDNA molecules that are tumor-derived, the cfDNA analogue of bulk-tumor purity) from shallow whole-genome sequencing with ichorCNA, an HMM over 1 Mb bins that jointly EM-estimates tumor fraction, ploidy, and subclonal prevalence over a normal/ploidy grid. Encodes the load-bearing reframes: tumor fraction is the quantity that travels across assays and is NOT mutation VAF (clonal-het VAF approximately TF/2), CNA-based estimation has a hard ~3 percent limit-of-detection floor, and near-diploid or copy-neutral-LOH genomes return a falsely low value. Selects the estimator by data type (sWGS to ichorCNA, deep panel to max-VAF, methylation to deconvolution, sub-3 percent to fragmentomics or methylation). Use when quantifying tumor burden from a liquid biopsy, picking a tumor-fraction estimator for a given assay, or reconciling a TF estimate against a panel VAF.

日本語の概要は準備中です。原文の説明を表示しています。

Detects cancer and infers tissue-of-origin from cfDNA methylation by choosing conversion chemistry (bisulfite vs EM-seq vs TAPS vs cfMeDIP), calling read-level methylation haplotypes rather than averaged beta values, and deconvolving a hematopoietic-dominated cfDNA mixture against a methylation atlas via NNLS/quadratic programming. Encodes the GRAIL/CCGA thesis that thousands of tissue-specific markers make methylation outperform sparse mutations for multi-cancer early detection (MCED) and localization, and that single concordantly-methylated fragments give ppm-level sensitivity. Uses MethylDackel for extraction (mbias-then-extract), MEDIPS/QSEA for enrichment data, scipy.optimize.nnls for deconvolution. Use when building an MCED or methylation-MRD assay, picking a conversion chemistry for low-input plasma, or deconvolving tissue-of-origin from cfDNA.

日本語の概要は準備中です。原文の説明を表示しています。

Estimates the minimum biological replicates (or cells/events) for a target power at a target FDR in genomics experiments using ssizeRNA, PROPER, powsimR for scRNA-seq, and pilot-data dispersion estimation from DESeq2/edgeR. Covers the biological-versus-technical replication distinction (technical replicates do not add degrees of freedom for biological inference), replicate-number-versus-sequencing-depth budgeting, scRNA-seq sample-versus-cell allocation under a pseudobulk model, and the critique that "n=3" is a publication convention rather than a power calculation. Use when budgeting a sequencing experiment, writing the sample-size justification in a grant, estimating replicates from pilot data, allocating a fixed budget between samples and depth, or planning scRNA-seq cohort size. For clinical-trial sample size see clinical-biostatistics/power-and-sample-size; for the power-given-n direction see experimental-design/power-analysis.

日本語の概要は準備中です。原文の説明を表示しています。

Normalizes and transforms RNA-seq count matrices for DE, visualization, clustering, and ML. Covers between-sample (TMM, TMMwsp, RLE/median-of-ratios, upper quartile), within-sample (TPM, FPKM/RPKM), variance-stabilizing (VST, rlog, log-CPM), GC-content correction (cqn, EDASeq), and single-cell (scran deconvolution, scanpy normalize_total). Encodes the composition-bias rationale, the "most genes not DE" assumption and its catastrophic failure modes (MYC amplification, apoptosis, viral host shutoff, prokaryotic stress), the "lengthScaledTPM is not TPM" naming trap, the "TPM is not for DE" rule, the blind=TRUE vs FALSE decision, ERCC spike-in normalization (SBN), and the single-cell zero-inflation breakdown of TMM/RLE. Use when choosing or applying normalization, debugging shifted-MA-plot diagnostics, handling zero-heavy single-cell data, or correcting GC bias.

日本語の概要は準備中です。原文の説明を表示しています。

Designs genomics experiments so technical nuisance variation (batch, lane, plate, flow cell, operator, reagent lot, processing day) is balanced against the biological variable of interest and therefore estimable rather than confounded, using constrained sample-to-batch assignment (designit, OSAT), the confounder/mediator/collider distinction, and the principle that no post-hoc correction recovers a fully confounded design. Covers detecting hidden batches with surrogate variable analysis, a decision table for downstream correction (ComBat-seq, RUVSeq, SVA) whose execution is deferred to differential-expression/batch-correction, and reproducibility metadata. Use when assigning samples to sequencing batches/lanes/plates, avoiding batch-condition confounding, deciding whether a design is salvageable by correction, choosing a correction method, or estimating the number of hidden batches. For the experimental unit, randomization, and blocking concepts see experimental-design/randomization-blocking.

日本語の概要は準備中です。原文の説明を表示しています。

Estimates SNP heritability and partitions it across functional annotations, cell types, and loci from GWAS summary statistics or individual-level genotypes. Implements LDSC, stratified LDSC with the baseline-LD model, Finucane 2018 cell-type prioritization, LDAK SumHer, HDL, HESS local heritability, BOLT-REML, GCTA-GREML, graphREML, and Popcorn cross-population genetic correlation. Use when computing total h2_SNP from summary stats, partitioning heritability across functional categories, prioritizing trait-relevant tissues or cell types from ENCODE/Roadmap chromatin marks, reconciling LDSC vs LDAK enrichment estimates, computing local heritability with HESS, estimating genetic correlation between traits, or producing publication-grade enrichment with calibrated sensitivity to model assumptions.

日本語の概要は準備中です。原文の説明を表示しています。

Expert guidance for simulating RoadRunner scenarios via the MATLAB programmatic API and Simulink co-simulation. Use when the user wants to run a simulation, step through a simulation, control actors during co-simulation, add observers, attach sensors, retrieve simulation logs, or read/write scenario variables. Covers simulateScenario, createSimulation, ScenarioSimulation set/get, ActorSimulation getAttribute/setAttribute, addObserver, SensorSimulation, Simulink co-sim blocks, and publishActorBehavior. NOT for project setup, scene building, scenario authoring, or trajectory export.

日本語の概要は準備中です。原文の説明を表示しています。

Generate, evaluate, and narrow brand concepts during early ideation including positioning territories, naming candidates, mood directions, and narrative angles. Use this skill whenever the user is in the early phase of brand creation, exploring brand directions, brainstorming names, building moodboards, generating positioning options, or trying to choose between multiple brand directions. Triggers on brand ideation, brand concept, naming, brand name, name candidates, positioning, brand positioning, mood board, brand directions, exploring brands, early brand work, brand exploration, brand brainstorm, brand options. Also triggers when the user has multiple half-formed brand ideas and needs help converging on one, even if they do not say 'ideation' explicitly.

日本語の概要は準備中です。原文の説明を表示しています。

A platform decision framework for experimentation. When to use Statsig vs PostHog vs GrowthBook vs Optimizely vs Amplitude vs Eppo vs Kameleoon. How to migrate between them. How to coordinate when multi-platform is genuinely warranted. The decisions that compound for years and the ones you can defer. Triggers on which experimentation platform, choose Statsig vs PostHog, evaluate experimentation tools, switch experimentation platform, migrate from Optimizely, consolidate experimentation tools, multi-platform experimentation, experimentation platform decision, ab test platform selection, feature flag platform vs experiment platform, warehouse-native experiments, vendor lock-in experimentation. Also triggers when a team is asking about cost, governance, or migration cost across experimentation tools, or when an evaluation is starting.

日本語の概要は準備中です。原文の説明を表示しています。

Content distribution as a discipline. Owned channels (newsletter, blog, social), earned channels (PR, syndication, mentions), paid channels (boosted posts, syndication networks), and the channel-fit decisions that distinguish strategic distribution from spam-everywhere. Audience-channel matching, content-channel matching, distribution cadence. Triggers on content distribution, channel strategy for content, owned earned paid channels, content amplification, content promotion, audience-channel matching, content-channel matching, distribution cadence, syndication strategy, organic distribution. Also triggers when content is publishing but reach is low, when the team is distributing on every channel without strategy, or when the content program needs a distribution discipline rather than just publication.

日本語の概要は準備中です。原文の説明を表示しています。

Analyze images, video, speech, motion, products, and websites; route local vision, audio, depth, tracking, matting, identity, and restoration models; auto-edit, replicate, enhance, caption, voice, assemble, annotate, validate, and export editable Timeline Studio projects and videos. Use for reference-video remakes, filter and repeated-shot reconstruction, subject-aware reframing, clip splitting, source-time speed curves, Color Wheels grading, ramps and holds, person or product cutout, person or object outline, authorized face swap, shot and timing reconstruction, timeline markers, chapters, beat cues, review notes and ranges, supplied or web-sourced footage, AI video platform selection, cleanup, highlights, product promotion, website walkthroughs, image-to-video assisted edits, optical-flow editing, depth-assisted relighting, grayscale depth-video conversion, depth/2.5D/transition finishing, AI voiceover, subtitles, short-form production, .timeline automation, or editor evaluation.

日本語の概要は準備中です。原文の説明を表示しています。

Elite incident response and legal compliance guidance for data breaches under GDPR Articles 33 & 34. Use when: (1) User reports a data breach or security incident — including "is this even a personal data breach?" triage, (2) User asks about breach notification obligations or deadlines, (3) User mentions "72 hours", Art. 33, Art. 34, or notification requirements, (4) Discussion involves security incidents affecting personal data, (5) User needs breach risk assessment using ENISA methodology, (6) User mentions "Data Breach" or "Incident" or "Data Leakage" or "Ransomware" or "Exfiltration", (7) User needs to determine Controller vs Processor obligations, (8) Cross-border breach scenarios requiring Lead SA determination, (9) User needs a mitigation playbook or immediate response recommendations, (10) User needs audit-ready breach documentation (.docx) or an EDPB-template-aligned breach notification / evidence file — including follow-up and withdrawal notifications, (11) Breach involves an AI system requiring AI Act Art. 73 serious incident screening.

日本語の概要は準備中です。原文の説明を表示しています。

Expert patterns for AnimationPlayer including track types (Value, Method, Audio, Bezier), root motion extraction, animation callbacks, procedural animation generation, call mode optimization, and RESET tracks. Use for timeline-based animations, cutscenes, or UI transitions. Trigger keywords: AnimationPlayer, Animation, track_insert_key, root_motion, animation_finished, RESET_track, call_mode, animation_set_next, queue, blend_times.

日本語の概要は準備中です。原文の説明を表示しています。